Galera Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Galera Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2019 to Q2 2024.
  • Galera Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $1.14M, a 11.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.14M -$150K -11.7% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $1.17M +$1.17M Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $1.21M +$1.17M +2719% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 $1.25M +$1.14M +1078% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $1.29M +$1.12M +665% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $0 -$229K -100% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $43K -$253K -85.5% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $106K -$268K -71.7% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $168K -$282K -62.7% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $229K -$297K -56.5% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $296K -$234K -44.2% Dec 31, 2021 10-K 2023-03-08
Q3 2021 $374K -$229K -38% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $450K -$225K -33.3% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 $526K -$219K -29.4% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $530K -$285K -35% Dec 31, 2020 10-K 2022-03-10
Q3 2020 $603K -$273K -31.2% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $675K Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $745K Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $815K Dec 31, 2019 10-K 2021-03-11
Q3 2019 $876K Sep 30, 2019 10-Q 2019-12-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.